Uncategorized
Study shows limited efficacy of third IOP-lowering agent
MILAN — Washout from topical medications in glaucoma patients before micro-stent implantation provided evidence of the effects of single or combined medical therapy on IOP. IOP-lowering topical medications are the mainstay of glaucoma therapy. In 50% of patients, two or more medications are prescribed. The additive effect of a second agent is well-established by several studies, but there is some question about the added effect of a third agent, Brian Flowers, MD, said at the annual joint meeting of Ocular Surgery News and the Italian Society of Ophthalmology.